ZNF382 and esophageal squamous cell carcinoma: The data showed that the ZNF382 promoter was hypermethylated in 87% (99/114) of ESCC tissues and in 33% (1/3) of normal oesophageal tissues, suggesting the frequent methylation of ZNF382 in ESCC (Fig. 1h–i and Table 1).